Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.
作者： James Cassidy , Leonard B. Saltz , Bruce J. Giantonio , Fairooz F. Kabbinavar , Herbert I. Hurwitz
DOI: 10.1007/S00432-009-0712-3
关键词: Retrospective cohort study 、 Bevacizumab 、 Medicine 、 Surgery 、 Chemotherapy 、 Internal medicine 、 Randomization 、 Metastasis 、 Cancer 、 Hematology 、 Oncology 、 Colorectal cancer
摘要: Background Bevacizumab is frequently combined with 5-fluorouracil-based chemotherapy for patients metastatic colorectal cancer (mCRC). The relative benefit of bevacizumab in older has not been widely studied and interest.
springer.com
paperity.org
researchgate.net 
core.ac.uk 参考文章(16)
大亮 高張, What's going on 進行結腸直腸がんに対してのオキサリプラチンを用いた一次治療におけるベバシズマブの上乗せ効果[Saltz LB, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzen F, Cassidy J 'Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase 3 study'] Mebio oncology. ,vol. 6, pp. 121- 123 ,(2009)
Brenda K. Edwards, Holly L. Howe, Lynn A. G. Ries, Michael J. Thun, Harry M. Rosenberg, Rosemary Yancik, Phyllis A. Wingo, Ahmedin Jemal, Ellen G. Feigal, Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden Cancer. ,vol. 94, pp. 2766- 2792 ,(2002) , 10.1002/CNCR.10593
Robert J. Goldberg, Joel M. Gore, Jerry H. Gurwitz, Joseph S. Alpert, Priscilla Brady, William Strohsnitter, Zouyao Chen, James E. Dalen, The impact of age on the incidence and prognosis of initial acute myocardial infarction: The Worcester Heart Attack Study American Heart Journal. ,vol. 117, pp. 543- 549 ,(1989) , 10.1016/0002-8703(89)90727-8
Robert D. Abbott, J.David Curb, Beatriz L. Rodriguez, Kamal H. Masaki, Jordan S. Popper, G.Webster Ross, Helen Petrovitch, Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. Journal of Clinical Epidemiology. ,vol. 56, pp. 479- 486 ,(2003) , 10.1016/S0895-4356(02)00611-X
Marc D. Silverstein, John A. Heit, David N. Mohr, Tanya M. Petterson, W. Michael O'Fallon, L. Joseph Melton, Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. JAMA Internal Medicine. ,vol. 158, pp. 585- 593 ,(1998) , 10.1001/ARCHINTE.158.6.585
Fairooz F. Kabbinavar, Julie Hambleton, Robert D. Mass, Herbert I. Hurwitz, Emily Bergsland, Somnath Sarkar, Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer Journal of Clinical Oncology. ,vol. 23, pp. 3706- 3712 ,(2005) , 10.1200/JCO.2005.00.232
Fairooz F. Kabbinavar, Herbert I. Hurwitz, Jing Yi, Somnath Sarkar, Oliver Rosen, Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials Journal of Clinical Oncology. ,vol. 27, pp. 199- 205 ,(2009) , 10.1200/JCO.2008.17.7931
G. Folprecht, D. Cunningham, P. Ross, B. Glimelius, F. Di Costanzo, J. Wils, W. Scheithauer, P. Rougier, E. Aranda, H. Hecker, C.-H. Köhne, Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials Annals of Oncology. ,vol. 15, pp. 1330- 1338 ,(2004) , 10.1093/ANNONC/MDH344
F. A. Scappaticci, J. R. Skillings, S. N. Holden, H.-P. Gerber, K. Miller, F. Kabbinavar, E. Bergsland, J. Ngai, E. Holmgren, J. Wang, H. Hurwitz, Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab Journal of the National Cancer Institute. ,vol. 99, pp. 1232- 1239 ,(2007) , 10.1093/JNCI/DJM086
Herbert Hurwitz, Shermini Saini, Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events. Seminars in Oncology. ,vol. 33, ,(2006) , 10.1053/J.SEMINONCOL.2006.08.001